Hematology Medical Science Liaison at Eli Lilly and Company

Monterrey, Nuevo Leon, Mexico

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, OncologyIndustries

Requirements

Education: MD, PharmD, PhD, or MSc strongly preferred; minimum bachelor’s in life sciences
Experience: ≥ 2 years in clinical practice, Medical Affairs, R&D, or related pharmaceutical roles
Language: Fluent English and Spanish; able to present complex data and manage Q&A in both
Scientific Communication: Proven record of high-impact presentations or publications
Technical Skills: Proficient in Microsoft Office; comfortable operating in a KPI/metrics-driven CRM environment
Relationship & Analytical Skills: Demonstrated ability to build multidisciplinary networks and convert qualitative interactions into strategic recommendations
Mobility: Willing and able to travel approx. 65% nationally, including overnight trips

Responsibilities

Scientific Engagement & Education – Deliver balanced, evidence-based presentations and tailored educational sessions to hematologists, breast cancer specialists, multidisciplinary care teams, and payer influencers, emphasizing the latest advances and clinical data lymphomas
KOL Relationship Management – Map, prioritize, and sustain trust-based partnerships with scientific & clinical experts
Insight Generation – Capture unmet needs and therapeutic trends; translate findings into concise reports that drive medical plans, evidence generation, and launch tactics
Cross-Functional Collaboration – Provide compliant scientific support to Access, Commercial, Regulatory, Marketing, Compliance, and any function requiring medical input in a non-promotion way
Compliance Leadership – Uphold Lilly’s zero-tolerance ethics culture and ensure all activities meet local/global standards and regulations

Skills

Medical Science Liaison

Hematology

KOL Engagement

Scientific Presentations

Insight Generation

Cross-Functional Collaboration

Lymphomas

Evidence-Based Education

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free